30-day FRN- 10 CFR Part 35

24750

Federal Register / Vol. 82, No. 102 / Tuesday, May 30, 2017 / Notices

For the Nuclear Regulatory Commission.
James G. Danna,
Chief, Plant Licensing Branch I–1, Division
of Operating Reactor Licensing, Office of
Nuclear Reactor Regulation.
[FR Doc. 2017–11040 Filed 5–26–17; 8:45 am]
BILLING CODE 7590–01–P

NUCLEAR REGULATORY
COMMISSION
[NRC–2017–0013]

Information Collection: ‘‘10 CFR Part
35, Medical Use of Byproduct Material’’
Nuclear Regulatory
Commission.
ACTION: Notice of submission to the
Office of Management and Budget;
request for comment.
AGENCY:

The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a request for renewal of an
existing collection of information to the
Office of Management and Budget
(OMB) for review. The information
collection is entitled, ‘‘10 CFR part 35,
Medical Use of Byproduct Material.’’
DATES: Submit comments by June 29,
2017.
SUMMARY:

Submit comments directly
to the OMB reviewer at: Aaron Szabo,
Desk Officer, Office of Information and
Regulatory Affairs, OMB clearance
number 3150–0010, NEOB–10202,
Office of Management and Budget,
Washington, DC 20503; telephone: 202–
395–3621, email: oira_submission@
omb.eop.gov.

ADDRESSES:

FOR FURTHER INFORMATION CONTACT:

David Cullison, NRC Clearance Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and
Submitting Comments

sradovich on DSK3GMQ082PROD with NOTICES

A. Obtaining Information
Please refer to Docket ID NRC–2017–
0013 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking Web site: Go to
http://www.regulations.gov and search
for Docket ID NRC–2017–0013. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing Docket ID
NRC–2017–0013 on this Web site.
• NRC’s Agencywide Documents
Access and Management System

VerDate Sep<11>2014

19:59 May 26, 2017

Jkt 241001

(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
http://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to [email protected]. The
supporting statement is available in
ADAMS under Accession No.
ML16333A028.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, David Cullison,
Office of the Chief Information Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
B. Submitting Comments
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC posts all comment
submissions at http://
www.regulations.gov as well as entering
the comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the OMB, then you
should inform those persons not to
include identifying or contact
information that they do not want to be
publicly disclosed in their comment
submission. Your request should state
that the NRC does not routinely edit
comment submissions to remove such
information before making the comment
submissions available to the public or
entering the comment submissions into
ADAMS.
Background
Under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35), the NRC recently
submitted a request for renewal of an
existing collection of information to
OMB for review entitled, ‘‘10 CFR part
35, Medical Use of Byproduct Material.’’
The NRC hereby informs potential
respondents that an agency may not
conduct or sponsor, and that a person is

PO 00000

Frm 00092

Fmt 4703

Sfmt 4703

not required to respond to, a collection
of information unless it displays a
currently valid OMB control number.
The NRC published a Federal
Register notice with a 60-day comment
period on this information collection on
February 1, 2017 (82 FR 8959).
1. The title of the information
collection: ‘‘10 CFR part 35, Medical
Use of Byproduct Material.’’
2. OMB approval number: 3150–0010.
3. Type of submission: Extension.
4. The form number if applicable:
N/A.
5. How often the collection is required
or requested: Reports of medical events,
doses to an embryo/fetus or nursing
child, or leaking source are reportable
on occurrence. A specialty board
certifying entity desiring to be
recognized by the NRC must submit a
one-time request for recognition and
infrequently revise the information.
6. Who will be required or asked to
respond: Physicians and medical
institutions holding an NRC license
authorizing the administration of
byproduct material or radiation from
this material to humans for medical use.
A specialty board certification entity
desiring to have its certifying process
and board certificate recognized by the
NRC.
7. The estimated number of annual
responses: 276,359 ((NRC: 36,313 + 962
recordkeepers = 37,275) + (Agreement
States: 232,925 + 6,157 recordkeepers +
2 specialty certification entity =
239,084)).
8. The estimated number of annual
respondents: 7,121(NRC: 962 +
Agreement states 6,157 + 2 specialty
certification entities).
9. An estimate of the total number of
hours needed annually to comply with
the information collection requirement
or request: 1,073,224 hours (NRC
Licensees 145,195 hrs. + Agreement
States 928,027 hrs. + specialty certifying
entities 2 hrs.).
10. Abstract: ‘‘10 CFR part 35,
Medical Use of Byproduct Material,’’
contains NRC’s requirements and
provisions for the medical use of
byproduct material and for issuance of
specific licenses authorizing the
medical use of this material. These
requirements and provisions provide for
the radiation safety of workers, the
general public, patients, and human
research subjects. Part 35 contains
mandatory requirements that apply to
NRC licensees authorized to administer
byproduct material or radiation
therefrom to humans for medical use.
These requirements also provide
voluntary provisions for specialty
boards to apply to have their
certification processes recognized by the

E:\FR\FM\30MYN1.SGM

30MYN1

Federal Register / Vol. 82, No. 102 / Tuesday, May 30, 2017 / Notices
NRC so that their board certified
individuals can use the certifications as
proof of training and experience.
Dated at Rockville, Maryland, this 23rd day
of May 2017.
For the Nuclear Regulatory Commission.
David Cullison,
NRC Clearance Officer, Office of the Chief
Information Officer.
[FR Doc. 2017–10967 Filed 5–26–17; 8:45 am]
BILLING CODE 7590–01–P

SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–80747; File No. SR–GEMX–
2017–10]

Self-Regulatory Organizations; Nasdaq
GEMX, LLC; Notice of Filing and
Immediate Effectiveness of Proposed
Rule Change Regarding the Opening
Process
May 23, 2017.

Pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’),1 and Rule 19b–4 thereunder,2
notice is hereby given that on May 10,
2017, Nasdaq GEMX, LLC (‘‘GEMX’’ or
‘‘Exchange’’) filed with the Securities
and Exchange Commission
(‘‘Commission’’) the proposed rule
change as described in Items I, II, and
III, below, which Items have been
prepared by the Exchange. The
Commission is publishing this notice to
solicit comments on the proposed rule
change from interested persons.
I. Self-Regulatory Organization’s
Statement of the Terms of Substance of
the Proposed Rule Change
The Exchange proposes to amend the
Opening Process for foreign currency
options and also amend a reference to
All-or-None Orders.
The text of the proposed rule change
is available on the Exchange’s Web site
at www.ise.com, at the principal office
of the Exchange, and at the
Commission’s Public Reference Room.

sradovich on DSK3GMQ082PROD with NOTICES

II. Self-Regulatory Organization’s
Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule
Change
In its filing with the Commission, the
Exchange included statements
concerning the purpose of and basis for
the proposed rule change and discussed
any comments it received on the
proposed rule change. The text of these
statements may be examined at the
places specified in Item IV below. The
1 15
2 17

U.S.C. 78s(b)(1).
CFR 240.19b–4.

VerDate Sep<11>2014

19:59 May 26, 2017

Jkt 241001

Exchange has prepared summaries, set
forth in sections A, B, and C below, of
the most significant aspects of such
statements.
A. Self-Regulatory Organization’s
Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule
Change
1. Purpose
The purpose of this rule change is to
amend GEMX Rule 701, entitled
‘‘Opening,’’ to: (i) Conform certain rule
text to that of Nasdaq ISE, LLC; (ii)
amend the Opening Process for foreign
currency options; and (iii) remove a
specific rule text reference in Rule 701
related to All-or-None Orders.
Conform Rule Text
ISE recently filed to adopt a new
Opening Process.3 In adopting this rule,
certain non-substantive modifications
were made to the rule text to further
clarify the manner in which the
Opening Process occurs. At this time,
the Exchange proposes to amend GEMX
Rule 701 to conform the text of the rule
to ISE Rule 701. Specifically, the
Exchange proposes to amend Rule
701(j)(5) to amend the last sentence to
make clear that any unexecuted
contracts from the imbalance process
which are not traded or routed will be
cancelled back to the entering
participant if they remain unexecuted
and priced through the Opening Price,
otherwise orders will remain in the
Order Book. The additional language
adds more detail about the interaction
with the Order Book to the rule.
Foreign Currency Options
GEMX Rule 701 provides that Market
Maker Valid Width Quotes and Opening
Sweeps received starting at 9:25 a.m.
Eastern Time, or 7:25 a.m. Eastern Time
for U.S. dollar-settled foreign currency
options, will be included in the
Opening Process. Orders entered at any
time before an option series opens are
included in the Opening Process. The
current Opening Process rule states that
the submission of Valid Width Quotes
and Opening Sweeps for U.S. dollarsettled foreign currency options may
begin at 7:25 a.m. Eastern Time to tie
the option Opening Process to quoting
in the underlying security 4; it presumes
that option quotes submitted before any
indicative quotes have been
disseminated for the underlying security
may not be reliable or intentional. The
Exchange proposes to amend GEMX
3 See Securities Exchange Act Release No. 80225
(March 13, 2017), 82 FR 14243 (March 17, 2017)
(SR–ISE–2017–02).
4 The underlying security can also be an index.

PO 00000

Frm 00093

Fmt 4703

Sfmt 4703

24751

Rule 701 so that the Opening Process for
foreign currency options would initiate
on or after 9:30 a.m. Eastern Time and
the Market Maker Valid Width Quotes
and Opening Sweeps would be
considered for the Opening Process
starting at 9:25 a.m. Eastern Time for
foreign currency options.
All-or-None Orders
The Exchange also proposes to amend
Rule 701 to remove a specific reference
to the manner in which All-or-None
Orders are treated in the Opening
Process. The Exchange filed a proposed
rule change to amend All-or-None
Orders.5 The Exchange amended Rule
715(c) to provide that an All-or-None
Order may only be entered into the
System with a time-in-force designation
of Immediate-or-Cancel 6 Order in
connection with the Exchange’s
technology migration to INET.
Previously, All-or-None Orders could
trade as a limit or market order to be
executed in its entirety or not at all.
With the amendment, an All-or-None
Order does not persist in the Order
Book. The carve out specified in Rule
701(j)(6)(i) is unnecessary since an Allor-None Order will execute immediately
or cancel. The Exchange believes
removing this reference will eliminate
confusion.
2. Statutory Basis
The Exchange believes that its
proposal is consistent with Section 6(b)
of the Act,7 in general, and furthers the
objectives of Section 6(b)(5) of the Act,8
in particular, in that it is designed to
promote just and equitable principles of
trade, to remove impediments to and
perfect the mechanism of a free and
open market and a national market
system, and, in general to protect
investors and the public interest for the
reasons stated below.
Conform Rule Text
The Exchange believes that
conforming the GEMX rule to the ISE
rule will avoid confusion for market
participants. The Opening Process is the
same on these two markets. By
conforming the rule text of these two
rules will make clear that there is no
difference in the operation of these two
Opening Processes.
5 See Securities Exchange Act Release No. 80102
(February 24, 2017, 82 FR 12381 (March 2, 2017)
(SR–ISEGemini–2017–08) (Notice of Filing and
Immediate Effectiveness of Proposed Rule Change
Related to All-or-None Orders).
6 An Immediate-or-Cancel Order is a limit order
that is to be executed in whole or in part upon
receipt. Any portion not so executed is to be treated
as cancelled.
7 15 U.S.C. 78f(b).
8 15 U.S.C. 78f(b)(5).

E:\FR\FM\30MYN1.SGM

30MYN1